المؤلفون: Jing Gao, Dimitrios Kalafatis, Lisa Carlson, Ida H. A. Pesonen, Chuan-Xing Li, Åsa Wheelock, Jesper M. Magnusson, C. Magnus Sköld

المصدر: Respiratory Research, Vol 22, Iss 1, Pp 1-13 (2021)

مصطلحات موضوعية: Idiopathic pulmonary fibrosis, Disease severity, Phenotype, Anti-fibrotic treatment, Survival, Diseases of the respiratory system, RC705-779

وصف الملف: electronic resource

Relation: https://doaj.org/toc/1465-993X

URL الوصول: https://doaj.org/article/69f748c5acc24d39ab251984584f4766

المؤلفون: Dimitrios Kalafatis, Jing Gao, Ida Pesonen, Lisa Carlson, C. Magnus Sköld, Giovanni Ferrara

المصدر: BMC Pulmonary Medicine, Vol 19, Iss 1, Pp 1-8 (2019)

مصطلحات موضوعية: Idiopathic pulmonary fibrosis, Gender perspective, Interstitial lung disease, Comorbidities, Registry, KBILD, Diseases of the respiratory system, RC705-779

وصف الملف: electronic resource

Relation: http://link.springer.com/article/10.1186/s12890-019-0994-4; https://doaj.org/toc/1471-2466

URL الوصول: https://doaj.org/article/ca3c7af037f64bfc9f978d567cccc835

المؤلفون: Dimitrios Kalafatis, Anna Löfdahl, Per Näsman, Göran Dellgren, Åsa M. Wheelock, Linda Elowsson Rendin, Magnus Sköld, Gunilla Westergren-Thorsson

المصدر: International Journal of Molecular Sciences, Vol 22, Iss 24, p 13421 (2021)

مصطلحات موضوعية: idiopathic pulmonary fibrosis, biomarkers, fibroblast, extracellular matrix, Biology (General), QH301-705.5, Chemistry, QD1-999

وصف الملف: electronic resource

Relation: https://www.mdpi.com/1422-0067/22/24/13421; https://doaj.org/toc/1661-6596; https://doaj.org/toc/1422-0067

URL الوصول: https://doaj.org/article/521ce8713fc84d399ea172a287643fd3

المؤلفون: C. Magnus Sköld, Jesper Magnusson, Jing Gao, Åsa M. Wheelock, Lisa Carlson, Dimitrios Kalafatis, Chuanxing Li, Ida Pesonen

المصدر: Respiratory Research, Vol 22, Iss 1, Pp 1-13 (2021)
Respiratory Research

مصطلحات موضوعية: Male, medicine.medical_specialty, Vital capacity, Anti-fibrotic treatment, Survival, Vital Capacity, Idiopathic pulmonary fibrosis, 03 medical and health sciences, FEV1/FVC ratio, 0302 clinical medicine, Quality of life, DLCO, Internal medicine, Medicine, Humans, Lung volumes, 030212 general & internal medicine, Longitudinal Studies, Registries, Survival rate, Protein Kinase Inhibitors, Disease severity, Aged, Sweden, lcsh:RC705-779, business.industry, Research, Hazard ratio, Anti-Inflammatory Agents, Non-Steroidal, lcsh:Diseases of the respiratory system, Middle Aged, medicine.disease, Survival Rate, Phenotype, 030228 respiratory system, Female, business, Follow-Up Studies

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::adb5158300fe65c2f866981a7cb2b77b
https://doaj.org/article/69f748c5acc24d39ab251984584f4766

المؤلفون: Michael T. Durheim, Tone Sjåheim, Charlotte Hyldgaard, Elisabeth Bendstrup, Marjukka Myllärniemi, Dimitrios Kalafatis, Lisa Carlson, Eva Sutinen, C. Magnus Sköld

المساهمون: HUS Heart and Lung Center, Department of Medicine, Keuhkosairauksien yksikkö, INDIVIDRUG - Individualized Drug Therapy, Research Programs Unit, University of Helsinki, Clinicum

المصدر: Durheim, M T, Bendstrup, E, Carlson, L, Sutinen, E M, Hyldgaard, C, Kalafatis, D, Myllärniemi, M, Sköld, C M & Sjåheim, T 2021, ' Outcomes of patients with advanced idiopathic pulmonary fibrosis treated with nintedanib or pirfenidone in a real-world multicentre cohort ', Respirology, vol. 26, no. 10, pp. 982-988 . https://doi.org/10.1111/resp.14116

مصطلحات موضوعية: Indoles, Vital Capacity, chemistry.chemical_compound, Idiopathic pulmonary fibrosis, 0302 clinical medicine, DLCO, nintedanib, 030212 general & internal medicine, Pyridones/therapeutic use, INDEX, interstitial lung disease, education.field_of_study, Hazard ratio, Pirfenidone, respiratory system, humanities, 3. Good health, Treatment Outcome, SAFETY, Disease Progression, Nintedanib, antifibrotic therapy, Indoles/therapeutic use, medicine.drug, Pulmonary and Respiratory Medicine, medicine.medical_specialty, Pyridones, Population, advanced idiopathic pulmonary fibrosis, DIAGNOSIS, 03 medical and health sciences, FEV1/FVC ratio, Internal medicine, medicine, Humans, education, Proportional hazards model, business.industry, MORTALITY, medicine.disease, EFFICACY, transplant-free survival, Idiopathic Pulmonary Fibrosis, respiratory tract diseases, Idiopathic Pulmonary Fibrosis/drug therapy, 030228 respiratory system, chemistry, 3121 General medicine, internal medicine and other clinical medicine, pirfenidone, business, FORCED VITAL CAPACITY

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7fe986efb391d30ca7852dd64120de55
https://pure.au.dk/portal/da/publications/outcomes-of-patients-with-advanced-idiopathic-pulmonary-fibrosis-treated-with-nintedanib-or-pirfenidone-in-a-realworld-multicentre-cohort(06f0874b-070a-4c34-99cf-bfd164a23607).html

المؤلفون: Magnus Sköld, Ida Pesonen, Lisa Carlson, Hiroki Tanahashi, Dimitrios Kalafatis, Kakuhiro Yamaguchi, Noboru Hattori, Jing Gao, Hiroshi Iwamoto, Yasushi Horimasu

المصدر: Idiopathic interstitial pneumonias.

مصطلحات موضوعية: medicine.medical_specialty, Idiopathic pulmonary fibrosis, business.industry, Internal medicine, medicine, In patient, business, medicine.disease, Gastroenterology

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::4c216f566d2e92dbbc47bbe6328e92ef
https://doi.org/10.1183/13993003.congress-2021.pa393

المؤلفون: Magnus Sköld, Dimitrios Kalafatis, Ida Pesonen, Lisa Carlson, Giovanni Ferrara, Jing Gao

المصدر: Respiratory Medicine: X, Vol 2, Iss, Pp 100017-(2020)

مصطلحات موضوعية: Pulmonary and Respiratory Medicine, lcsh:Immunologic diseases. Allergy, medicine.medical_specialty, Vital capacity, Physiology, Idiopathic pulmonary fibrosis, FEV1/FVC ratio, DLCO, Internal medicine, medicine, Lung volumes, Registries, lcsh:RC705-779, Lung, business.industry, Proportional hazards model, Interstitial lung disease, lcsh:Diseases of the respiratory system, respiratory system, medicine.disease, respiratory tract diseases, medicine.anatomical_structure, Walk test, business, lcsh:RC581-607, Lung volume measurements

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a6c82c7dd4368ed774c38f96788bdfde
http://www.sciencedirect.com/science/article/pii/S259014352030004X

المؤلفون: Dimitrios Kalafatis, Ida Pesonen, Chuanxing Li, C. M. Skold, Lisa Carlson, Jing Gao

المصدر: Idiopathic interstitial pneumonias.

مصطلحات موضوعية: Idiopathic pulmonary fibrosis, medicine.medical_specialty, business.industry, Internal medicine, medicine, In patient, medicine.disease, Disease cluster, business, Gastroenterology

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::91c16def0596c670799b0e28b529f6c5
https://doi.org/10.1183/13993003.congress-2020.1840

المؤلفون: Ida Pesonen, Dimitrios Kalafatis, Magnus Sköld, Lisa Carlson, Jing Gao, Chuanxing Li

المصدر: Idiopathic interstitial pneumonias.

مصطلحات موضوعية: medicine.medical_specialty, business.industry, Pirfenidone, respiratory system, medicine.disease, respiratory tract diseases, FEV1/FVC ratio, Idiopathic pulmonary fibrosis, chemistry.chemical_compound, chemistry, DLCO, Baseline characteristics, Internal medicine, Cohort, medicine, Nintedanib, Stage (cooking), business, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::df757ae51cea5d5b5762c6660ec109bd
https://doi.org/10.1183/13993003.congress-2020.1843

المؤلفون: Lisa Carlson, Giovanni Ferrara, Ida Pesonen, Dimitrios Kalafatis, Magnus Sköld

المصدر: Idiopathic interstitial pneumonias.

مصطلحات موضوعية: Vital capacity, medicine.medical_specialty, business.industry, Autoantibody, respiratory system, medicine.disease, Gastroenterology, respiratory tract diseases, Idiopathic pulmonary fibrosis, FEV1/FVC ratio, DLCO, Diffusing capacity, Internal medicine, medicine, Rheumatoid factor, Lung volumes, business

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::f652c37f700b9f3d9437b6a62cef1392
https://doi.org/10.1183/13993003.congress-2019.pa4713